rs116448422
Variant summary
Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2
The NM_001039141.3(TRIOBP):c.504C>A(p.Asp168Glu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00104 in 1,614,076 control chromosomes in the GnomAD database, including 18 homozygotes. In-silico tool predicts a benign outcome for this variant. 14/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).
Frequency
Consequence
NM_001039141.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -20 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
TRIOBP | NM_001039141.3 | c.504C>A | p.Asp168Glu | missense_variant | 6/24 | ENST00000644935.1 | NP_001034230.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
TRIOBP | ENST00000644935.1 | c.504C>A | p.Asp168Glu | missense_variant | 6/24 | NM_001039141.3 | ENSP00000496394.1 | |||
ENSG00000100101 | ENST00000455236.4 | n.*840C>A | non_coding_transcript_exon_variant | 12/13 | 5 | ENSP00000477208.1 | ||||
ENSG00000100101 | ENST00000455236.4 | n.*840C>A | 3_prime_UTR_variant | 12/13 | 5 | ENSP00000477208.1 |
Frequencies
GnomAD3 genomes AF: 0.00539 AC: 821AN: 152180Hom.: 7 Cov.: 32
GnomAD3 exomes AF: 0.00136 AC: 338AN: 248322Hom.: 5 AF XY: 0.00102 AC XY: 138AN XY: 134914
GnomAD4 exome AF: 0.000588 AC: 860AN: 1461778Hom.: 11 Cov.: 32 AF XY: 0.000494 AC XY: 359AN XY: 727188
GnomAD4 genome AF: 0.00539 AC: 821AN: 152298Hom.: 7 Cov.: 32 AF XY: 0.00500 AC XY: 372AN XY: 74472
ClinVar
Submissions by phenotype
not specified Benign:2
Benign, criteria provided, single submitter | clinical testing | Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine | May 07, 2012 | Asp168Glu in Exon 06 of TRIOBP: This variant is not expected to have clinical si gnificance because it has been identified in 2.1% (67/3156) of African American chromosomes from a broad population by the NHLBI Exome Sequencing Project (http: //evs.gs.washington.edu/EVS; dbSNP rs116448422). - |
Benign, criteria provided, single submitter | clinical testing | Eurofins Ntd Llc (ga) | May 31, 2016 | - - |
not provided Benign:2
Benign, criteria provided, single submitter | clinical testing | GeneDx | Jan 29, 2020 | - - |
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 09, 2024 | - - |
Autosomal recessive nonsyndromic hearing loss 28 Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Fulgent Genetics, Fulgent Genetics | Sep 08, 2021 | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at